Hemophilia B Treatment Market

Hemophilia B Treatment Market Analysis, By Treatment Type (Recombinant Factor IX Concentrates, Plasma-Derived Factor IX Concentrates, Gene Therapy, and Extended Half-Life Factor IX) By Patient Demographics (Pediatrics and Adults) By Severity of Hemophilia B (Mild Hemophilia B, Moderate Hemophilia B, and Severe Hemophilia B) By Distribution Channel (Hospitals, Specialty Clinics, and Online Pharmacies), and Region - Market Insights 2024 to 2034